Table of Contents
1. Research Methodology
1.1. Secondary Research
1.2. Primary Research
1.3. Market Estimation
1.4. Market Forecasting
2. Executive Summary
3. Market Overview
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Key Market Trends
3.2. Industry Speaks
4. Global Packaging & Labeling CDMO Market - Size &
Forecast (2026-2031), By Services
4.1. Primary & Secondary
Packaging
4.2. Serialization and Track
& Trace
4.3. Label Design & Printing
4.4. Compliance & Regulatory
Services
4.5. Supply Chain Management
4.6. Other Services
5. Global Packaging & Labeling CDMO Market - Size &
Forecast (2026-2031), By Sector
5.1. Pharmaceutical/Biopharma
Companies
5.2. Biotechnology Companies
5.3. MedTech Companies
5.4. Others
6. Global Packaging & Labeling CDMO Market - Size &
Forecast (2026-2031), By Region
6.1. North America (U.S. &
Canada)
6.2. Europe (UK, Germany, France,
Italy, Spain, Rest of Europe)
6.3. Asia Pacific (China, India,
Japan, Rest of Asia Pacific)
6.4. Rest of the World (Latin
America, Middle East & Africa)
7. Competitive Landscape
7.1. Key Players and their
Competitive Positioning
7.1.1. Competitive Positioning of
Key Players (2022)
7.1.2. Offerings Assessment, By
Player
7.2. Key Strategies Assessment,
By Player (2021-2023)
7.2.1. New Product & Service
Launches
7.2.2. Partnerships, Agreements,
& Collaborations
7.2.3. Mergers & Acquisitions
7.2.4. Geographic Expansion
8. Key Companies Scanned (Indicative List)
8.1. Aphena Pharma Solutions
8.2. Eurofins Scientific
8.3. Catalent
8.4. PCI Pharma
8.5. Pfizer CentreOne
8.6. Becton, Dickinson & Co
8.7. Almac Group
8.8. Jabil
8.9. Tecomet
8.10. Integer
8.11. Other Prominent Players